The risk of clinically significant prostate cancer on subsequent biopsies in men with HGPIN/ASAP on an MRI-informed index biopsy. Moser AM, Elanjian A, Zamani A, Ginsburg KB, et al. J Urol 2025 Sep 29:101097JU0000000000004797. doi: 10.1097/JU.0000000000004797.

Read + Share

Amedeo Smart

Independent Medical Education

Moser AM, Elanjian A, Zamani A, Ginsburg KB, et al. The risk of clinically significant prostate cancer on subsequent biopsies in men with HGPIN/ASAP on an MRI-informed index biopsy. J Urol 2025 Sep 29:101097JU0000000000004797. doi: 10.1097/JU.0000000000004797.
PMID: 41022044